The short version
- Why people research itAmplified natural GH release for recovery, sleep and body composition.
- What the evidence isNo trial of the combination.
- What to watchPersistent puffiness or hand numbness.
How CJC No Dac/Ipamorelin works
Start with the name, because it is wrong, and the error is not cosmetic. CJC-1295 is a specific molecule: modified GRF(1-29) carrying a drug affinity complex — a maleimidopropionyl group that forms a covalent bond with circulating albumin, giving a half-life of days Teichman 2006.
What mod GRF(1-29) actually is. Sermorelin — GHRH(1-29) — with four substitutions: D-Ala at position 2, Gln at 8, Ala at 15 and Leu at 27. The first is the important one.
- Injectable
On the goal map: Sleep depth, slow-wave & recovery quality (Sleep better)
Research on CJC No Dac/Ipamorelin4 evidence notes: clinical, correlative, mechanism
Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work
Human clinical evidence
No trial of the combination. The components are separately characterized in humans — CJC-1295 without DAC (modified GRF 1-29) has published PK, and ipamorelin reached phase 2 — but nobody has run the pair against placebo, so the synergy is inferred rather than demonstrated.
No completed human trial
Correlative data
The most-used peptide stack in practice, by a wide margin. The reported pattern is consistent enough to be worth something: deeper sleep in the first fortnight, recovery and skin changes over one to three months, body-composition change slowest of all.
How the mechanism reads
Two different receptors, one outcome. The GHRH analog raises the amplitude of the GH pulse; the ghrelin agonist increases pulse frequency and blunts somatostatin. Combining them is predicted to produce a bigger pulse than either alone, when the natural pulse already occurs.
MechanisticThe same logic predicts the ceiling: this amplifies a pulse, so it does little for someone whose pituitary output is genuinely gone.
Mechanistic
Sources
- Damjanovic S, et al. Pituitary enlargement due to primary hypothyroidism: growth hormone response to GHRH, GHRP-6 and GHRH plus GHRP-6. Journal of Pediatric Endocrinology and Metabolism 1996 · PMID 8961133
- McMahon CD, et al. GH-releasing peptide-6 overcomes refractoriness of somatotropes to GHRH after feeding. Journal of Endocrinology 2001 · PMID 11431156
- Fintini D, et al. Effects of combined long-term treatment with a growth hormone-releasing hormone analogue and a growth hormone secretagogue in the growth hormone-releasing hormone knock out mouse. Neuroendocrinology 2005 · PMID 16601359
CJC No Dac/Ipamorelin safety basicsWho should avoid it, what to expect, what to watch
Avoid if
- Active cancer, since combined GHRH and GHRP drive raises IGF-1 further than either alone.
- Diabetes, prediabetes or rising fasting glucose.
- Already using MK-677 or another ghrelin-receptor agonist, which double-loads the ipamorelin half.
- Carpal tunnel syndrome or fluid retention.
- Pregnancy, or an adolescent whose growth plates have not closed.
What’s expected
- A larger GH pulse than either peptide alone, shaped by the GHRH amplitude and the GHRP amplifier.
- Hunger and a flushed feel as ipamorelin hits GHS-R1a.
- Mild water retention from the combined GH and IGF-1 rise.
Watch for
- Persistent puffiness or hand numbness.
- Rising glucose.
- Declining response over time, the ghrelin-receptor side wearing off.
Labs that tell you it’s working
- IGF-1: the cumulative output of both pulses.
- Insulin (Fasting): GH-driven insulin resistance.
- HbA1c: the glucose cost if the combination runs high.
- Cortisol: ipamorelin is selective, so cortisol should stay flat; a rise means the selectivity failed.
GHRH analog plus GHS-R1a agonist: synergistic pituitary GH release; GHS-R side desensitizes while the GHRH side is not shown to. PMID 16601359 PMID 11431156
Bloodwork to runHow you would know it is working: 9 tests in one order, code CAMERON
A panel picked from how it works and what it can move: the tests, and why each is on it.
Code CAMERON applies automatically. The before and after schedule and how to read the results are in the Skool lesson.
CJC No Dac/Ipamorelin FAQ4 common questions
- Is CJC No Dac/Ipamorelin approved for human use?
- No. CJC No Dac/Ipamorelin is a research compound. No completed randomized human trial has given it yet.
- What is CJC No Dac/Ipamorelin researched for?
- Amplified natural GH release for recovery, sleep and body composition.
- Which labs show whether it's doing anything?
- IGF-1; Insulin; HbA1c; Cortisol: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
- Where's the full protocol?
- In the Skool lesson for CJC No Dac/Ipamorelin: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.





